WeTrials
Recruiting

Comparison of Immunogenicity of Different Influenza Vaccines in Patients With Hematologic Malignancies

What is this study?

This study is testing three different flu shots to see which one works best for people with blood cancers. Because these treatments can weaken the immune system, finding the most effective flu vaccine is very important to keep patients safe.

Who can participate?

You may be able to join if you are 19 or older and have been diagnosed with a blood-related cancer, such as leukemia, lymphoma, or plasma cell disorders. You also must not have received a flu shot in the past six months.

What will happen?

Participants will receive one of the three flu vaccine options being studied and will have their blood drawn regularly to check how well their body builds an immune defense. The study team will closely monitor your health and safety throughout the process.

Where and when?

This study is currently recruiting participants and takes place in Seoul, South Korea.

Key Points
  • 1Testing three different flu vaccines in patients with blood-related cancers
  • 2Aiming to find the best protection for people with weaker immune systems
  • 3Currently recruiting patients in Seoul, South Korea

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Hematologic NeoplasmsInfluenzaImmunogenicity

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.